Vaxart shareholders reject reverse stock split and say-on-pay proposals

Vaxart, Inc.

Reverse stock split amendment failed with 63.6M for, 91.9M against; company evaluating next steps.
Advisory say-on-pay proposal rejected: 34.4M for, 71.5M against, with 7.4M abstentions.
All six director nominees elected; David Wheadon received 46.5M for, 66.8M withheld.
Ratification of WithumSmith+Brown as auditor passed with 110.1M for, 38.0M against.
ATM facility in place with no shares sold as of June 13; special meeting on June 30 cancelled.

item 5.07item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.